Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, Lasa Supergenerics has informed that the Board of Directors in their meeting held today which was commenced at 11:00 am and concluded at 01:30 pm have considered and approved the following: The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2021and recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. A copy of the statement of audited Financial Results, Cash Flow statement along with Audited Report submitted by the Statutory Auditors of the Company is attached. The above information is also available on the company’s website at www.lasalabs.com and on the website of the stock Exchange at www.bseindia.com and www.nseindia.com.
The above information is a part of company’s filings submitted to BSE.
